跳至主要内容
临床试验/IRCT2014052014521N3
IRCT2014052014521N3已完成2 期

Comparison of curcumin’s effects in simple and modified formulations on cardiovascular risk factors in patients with metabolic syndrome

Mashhad University of Medical Sciences0 个研究点目标入组 120 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
入组人数
120

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 65 years(—)
性别
All

入选标准

  • Inclusion criteria : Men and women aged 18-65 years ; Metabolic Syndrome patients (based on IDF guidelines) ; Consent to participate in research project ; Not taking any dietary supplement ; Not taking any drugs within the last 3-6 months (Not history of taking any lipid-lowering, diabetes and hypertension drugs or insulin within the last 3-6 months) .
  • Exclusion criteria : Lack of informed consent of patient to participate in research project ; Having systemic disease or history of systemic disease (such as lupus and kidney disease) ; Not having Metabolic Syndrome ; Pregnancy or lactation ; Consumption of any drug supplement or lipid-lowering drug within the last 3-6 months ; Metabolic syndrome subjects who need to take any drug (based on American Heart Association guidelines) .

排除标准

  • 未提供

研究者

相似试验